Mari Raki

Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF

Anniina Koski, Lotta Kangasniemi, Sophie Escutenaire et al. · Molecular Therapy · 2010 · 251 citations · Full text

Medicine, Immunology, Oncology +17

Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients

Vincenzo Cerullo, Sari Pesonen, Iulia Diaconu et al. · Cancer Research · 2010 · 227 citations

Medicine, Immunology, Oncology +17

Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors

Petri Nokisalmi, Sari Pesonen, Sophie Escutenaire et al. · Clinical Cancer Research · 2010 · 116 citations

Medicine, Oncology, Pharmacology +16

Integrin targeted oncolytic adenoviruses Ad5‐D24‐RGD and Ad5‐RGD‐D24‐GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors

Sari Pesonen, Iulia Diaconu, Vincenzo Cerullo et al. · International Journal of Cancer · 2011 · 99 citations · Full text

Medicine, Immunology, Oncology +17

Combination of gemcitabine and Ad5/3-Δ24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer

Mari Raki, Anna Kanerva, Ari Ristimäki et al. · Gene Therapy · 2005 · 85 citations

Medicine, Molecular Biology, Oncology +12